相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors
Jamieson Bretz et al.
BLOOD (2011)
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
Santiago Montes-Moreno et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
Lisa M. Rimsza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Heinz-Wolfram Bernd et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
Sarah T. Wilkinson et al.
LEUKEMIA & LYMPHOMA (2009)
MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?
Arjan Diepstra
LEUKEMIA & LYMPHOMA (2009)
MHC II and the Endocytic Pathway: Regulation by Invariant Chain
O. J. B. Landsverk et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M. Rimsza et al.
BLOOD (2008)
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways
M. Booman et al.
JOURNAL OF PATHOLOGY (2008)
Distribution patterns of dendritic cells and T cells in Diffuse large B-cell lymphomas correlate with prognoses
Kung-Chao Chang et al.
CLINICAL CANCER RESEARCH (2007)
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
Arjan Diepstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy
H. Veelken et al.
ANNALS OF ONCOLOGY (2007)
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen
Lisa M. Rimsza et al.
LEUKEMIA & LYMPHOMA (2007)
Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics
M. Booman et al.
JOURNAL OF PATHOLOGY (2006)
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Robin A. Roberts et al.
BLOOD (2006)
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
L Pasqualucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
LM Rimsza et al.
BLOOD (2006)
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach
JS Abramson et al.
BLOOD (2005)
Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas
B Drénou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients
J Teruya-Feldstein et al.
ANNALS OF ONCOLOGY (2004)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Plasma cell ontogeny defined by quantitative changes in Blimp-1 expression
A Kallies et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities
L Colomo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
分享论文
